The Marygold Companies, Inc. Announces Proposed Public Offering of Common Stock
The Marygold Companies (NYSE American: MGLD) has announced an underwritten public offering of its common stock. The company plans to grant the underwriter, Maxim Group , a 45-day option to purchase up to an additional 15% of the offered shares at the public offering price, less underwriting discounts and commissions.
The net proceeds will be used to:
- Retire or reduce debt
- Make capital contributions to Marygold & Co. subsidiaries in the U.S. and U.K.
- Fund general working capital and corporate purposes
The offering is being made through an effective shelf registration statement on Form S-3 filed with the SEC on December 18, 2024, and declared effective on December 27, 2024. The completion, size, and terms of the offering are subject to market conditions.
Marygold Companies (NYSE American: MGLD) ha annunciato un'offerta pubblica di azioni ordinarie garantita. L'azienda prevede di concedere all'underwriter, Maxim Group, un'opzione di 45 giorni per acquistare fino al 15% aggiuntivo delle azioni offerte al prezzo dell'offerta pubblica, al netto degli sconti e delle commissioni di underwriting.
I proventi netti saranno utilizzati per:
- Estinguere o ridurre il debito
- Effettuare contributi di capitale alle controllate di Marygold & Co. negli Stati Uniti e nel Regno Unito
- Finanziare il capitale circolante e fini aziendali generali
L'offerta avviene attraverso una dichiarazione di registrazione a scaffale efficace sul modulo S-3 depositata presso la SEC il 18 dicembre 2024 e dichiarata efficace il 27 dicembre 2024. Il completamento, le dimensioni e le condizioni dell'offerta sono soggetti alle condizioni di mercato.
Las empresas Marygold (NYSE American: MGLD) han anunciado una oferta pública de acciones ordinarias bajo suscripción. La compañía planea conceder al suscriptor, Maxim Group, una opción de 45 días para comprar hasta un 15% adicional de las acciones ofrecidas al precio de la oferta pública, menos los descuentos y comisiones de suscripción.
Los ingresos netos se utilizarán para:
- Retirar o reducir la deuda
- Realizar aportes de capital a las subsidiarias de Marygold & Co. en EE. UU. y el Reino Unido
- Financiar el capital de trabajo general y propósitos corporativos
La oferta se realiza a través de una declaración de registro en estante efectiva en el Formulario S-3 presentada ante la SEC el 18 de diciembre de 2024 y declarada efectiva el 27 de diciembre de 2024. La finalización, tamaño y términos de la oferta están sujetos a las condiciones del mercado.
메리골드 컴퍼니(Marygold Companies) (NYSE American: MGLD)가 일반 주식의 공모를 발표했습니다. 회사는 인수인 Maxim Group에게 공모 가격에 따라 제공된 주식의 최대 15%를 추가로 구매할 수 있는 45일 옵션을 부여할 계획입니다. 단, 인수 수수료 및 할인은 제외됩니다.
순수익은 다음과 같은 용도로 사용될 예정입니다:
- 부채 상환 또는 축소
- 미국과 영국에 있는 Marygold & Co. 자회사에 자본 기여
- 일반 운영 자금 및 기업 목적 자금 지원
이 공모는 2024년 12월 18일에 SEC에 제출된 유효한 선반 등록 서류 양식 S-3를 통해 이루어지며, 2024년 12월 27일에 유효하다고 선언되었습니다. 공모의 완료, 규모 및 조건은 시장 상황에 따라 달라질 수 있습니다.
Les entreprises Marygold (NYSE American: MGLD) ont annoncé une offre publique souscrite de leurs actions ordinaires. L'entreprise prévoit d'accorder à l'agent de placement, Maxim Group, une option de 45 jours pour acheter jusqu'à 15 % supplémentaires des actions offertes au prix de l'offre publique, moins les remises et commissions de souscription.
Le produit net sera utilisé pour :
- Rembourser ou réduire la dette
- Effectuer des contributions en capital aux filiales de Marygold & Co. aux États-Unis et au Royaume-Uni
- Financer le fonds de roulement général et les objectifs d'entreprise
L'offre est réalisée par le biais d'une déclaration d'enregistrement en continu effective sur le formulaire S-3 déposée auprès de la SEC le 18 décembre 2024, qui a été déclarée efficace le 27 décembre 2024. L'achèvement, la taille et les conditions de l'offre sont soumis aux conditions du marché.
Die Marygold Companies (NYSE American: MGLD) haben ein unterzeichnetes öffentliches Angebot ihrer Stammaktien angekündigt. Das Unternehmen plant, dem Underwriter, Maxim Group, eine 45-tägige Option einzuräumen, um bis zu 15 % der angebotenen Aktien zum öffentlichen Angebotspreis, abzüglich Unterzeichnungskosten und Provisionen, zusätzlich zu erwerben.
Die Nettoeinnahmen werden verwendet für:
- Verpflichtungen abzulösen oder zu reduzieren
- Kapitalbeiträge an die Tochtergesellschaften von Marygold & Co. in den USA und im Vereinigten Königreich zu leisten
- Allgemeines Betriebskapital und Unternehmenszwecke zu finanzieren
Das Angebot erfolgt durch eine wirksame Shelf-Registrierungserklärung auf dem Formular S-3, die am 18. Dezember 2024 bei der SEC eingereicht und am 27. Dezember 2024 für wirksam erklärt wurde. Der Abschluss, die Größe und die Bedingungen des Angebots unterliegen den Marktbedingungen.
- Potential debt reduction through offering proceeds
- Capital injection planned for U.S. and U.K. subsidiaries
- Effective shelf registration already in place
- Potential shareholder dilution from new stock issuance
- Additional 15% share dilution possible through underwriter option
Insights
This public offering announcement represents a significant strategic move for The Marygold Companies, signaling both opportunities and challenges ahead. The decision to raise capital through equity rather than debt financing suggests a strategic pivot towards strengthening the balance sheet while potentially diluting existing shareholders.
The planned use of proceeds reveals three critical priorities:
- Debt reduction, indicating a focus on improving the capital structure
- Capital contributions to Marygold & Co. subsidiaries in both the U.S. and U.K., suggesting expansion plans
- Working capital enhancement, providing operational flexibility
The timing of this offering, following the December 2024 shelf registration, appears deliberate and suggests careful market positioning. The inclusion of a 45-day overallotment option provides flexibility to capture additional demand if market conditions prove favorable.
However, investors should note several key considerations:
- The final offering size and price remain undetermined, creating uncertainty about the extent of potential dilution
- The absence of specific allocation details for the proceeds leaves questions about the prioritization of stated uses
- The choice of Maxim Group as sole book-runner indicates a targeted approach to distribution
This capital raise could mark a pivotal moment for Marygold's growth trajectory, particularly in strengthening its financial subsidiaries. However, the success will largely depend on market reception and the company's ability to effectively deploy the new capital.
Maxim Group LLC is acting as the sole book-running manager for the proposed offering.
Marygold intends to use the net proceeds of this offering to retire or reduce debt, make further capital contributions to the Marygold & Co. subsidiaries in the
The public offering is being made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-283898), previously filed with the
This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
About The Marygold Companies, Inc.
The Marygold Companies was founded in 1996 and repositioned as a global holding firm in 2015. The Company currently has operating subsidiaries in financial services, food manufacturing, printing, security systems and beauty products, under the trade names USCF Investments, Marygold & Co., Marygold & Co. Limited, Step By Step Financial Planners, Gourmet Foods, Printstock Products, Brigadier Security Systems and Original Sprout, respectively. Offices and manufacturing operations are in the
Forward-Looking Statements
This press release contains forward-looking statements that are based on the Company’s beliefs and assumptions and on information currently available to the Company on the date of this press release. These forward-looking statements involve substantial risks and uncertainties. Any statements in this press release other than statements of historical fact, including statements about the Company’s future expectations, plans and prospects, constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include any statements about the Company’s strategy, operations and future expectations and plans and prospects for the Company, and any other statements containing the words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “goal,” “may,” “might,” “plan,” “predict,” “project,” “seek,” “target,” “potential,” “will,” “would,” “could,” “should,” “continue,” and similar expressions. Such forward-looking statements involve substantial risks and uncertainties that could cause the Company’s financial and operating results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements, including the factors discussed in the “Risk Factors” section contained in the quarterly and annual reports that the Company files with the Securities and Exchange Commission. Any forward-looking statement represents the Company’s views only as of the date of this press release. The Company anticipates that subsequent events and developments may cause its views to change. While the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so except as required by law even if new information becomes available in the future.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250124981899/en/
Media and investors, for more Information, contact:
Roger S. Pondel
PondelWilkinson Inc.
310-279-5965
rpondel@pondel.com
Contact the Company:
David Neibert, Chief Operations Officer
949-429-5370
dneibert@themarygoldcompanies.com
Source: The Marygold Companies, Inc.
FAQ
What is the purpose of MGLD's 2024 public stock offering?
How many additional shares can the underwriter purchase in MGLD's offering?
When was MGLD's shelf registration statement declared effective?
What is the expected size of MGLD's public offering?